Improving HIV prevention and treatment for people who inject drugs in Ukraine
A social network approach for improving medication assisted treatment and HIV prevention and medical care among people who inject drugs in Ukraine
This study is looking to improve support for people who inject drugs in Ukraine by helping those already on medication-assisted treatment to share their experiences and encourage others to get the help they need for both drug use and HIV care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10676829 on NIH RePORTER |
What this research studies
This research aims to enhance medication-assisted treatment (MAT) and HIV medical care among people who inject drugs (PWID) in Ukraine. It will involve recruiting individuals who have been on MAT for at least a year and can engage their drug-using networks to promote MAT and HIV care. Participants will be randomly assigned to either an intervention group, where they will receive training to support their peers, or a comparison group. The study will assess the effectiveness of this approach in increasing MAT uptake, reducing HIV transmission, and improving adherence to HIV treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs, particularly those who have been on medication-assisted treatment for at least one year and are willing to engage their peers.
Not a fit: Patients who do not inject drugs or those who are not interested in participating in peer support initiatives may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to HIV prevention and treatment services for people who inject drugs.
How similar studies have performed: Previous research has shown that peer-led interventions can be effective in improving health outcomes among drug-using populations, suggesting potential success for this approach.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Latkin, Carl a — Johns Hopkins University
- Study coordinator: Latkin, Carl a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.